Norvegia -
norvegiană -
Statens legemiddelverk
genvoya
orifarm as - elvitegravir / kobicistat / emtricitabin / tenofoviralafenamidfumarat - tablett, filmdrasjert - 150 mg / 150 mg / 200 mg / 10 mg
Norvegia -
norvegiană -
Statens legemiddelverk
rimactan 300 mg
orifarm as - rifampicin - kapsel, hard - 300 mg
Norvegia -
norvegiană -
Statens legemiddelverk
darunavir accord 800 mg
accord healthcare b.v. - darunavirpropylenglykolat - tablett, filmdrasjert - 800 mg
Norvegia -
norvegiană -
Statens legemiddelverk
darunavir accord 600 mg
accord healthcare b.v. - darunavirpropylenglykolat - tablett, filmdrasjert - 600 mg
Norvegia -
norvegiană -
Statens legemiddelverk
fentanyl ratiopharm 75 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 75 mikrog/ time
Norvegia -
norvegiană -
Statens legemiddelverk
fentanyl ratiopharm 12 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 12 mikrog/ time
Norvegia -
norvegiană -
Statens legemiddelverk
fentanyl ratiopharm 25 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 25 mikrog/ time
Norvegia -
norvegiană -
Statens legemiddelverk
fentanyl ratiopharm 50 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 50 mikrog/ time
Norvegia -
norvegiană -
Statens legemiddelverk
fentanyl ratiopharm 100 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 100 mikrog/ time
Uniunea Europeană -
norvegiană -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.